Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone). Issue 6 (12th May 2022)

Record Type:: Journal Article
Title:: Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone). Issue 6 (12th May 2022)
Main Title:: Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone)
Authors:: Naka, Ryosuke
Tada, Kohei
Kaneko, Hitomi
Nagata, Osamu
Tashima, Masaharu
Mizutani, Chisato
Imada, Kazunori
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 63:Issue 6(2022)
Journal:: Leukemia & lymphoma
Issue:: Volume 63:Issue 6(2022)
Issue Display:: Volume 63, Issue 6 (2022)
Year:: 2022
Volume:: 63
Issue:: 6
Issue Sort Value:: 2022-0063-0006-0000
Page Start:: 1508
Page End:: 1511
Publication Date:: 2022-05-12
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2022.2032040 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21745.xml